The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,780.50
Bid: 1,778.50
Ask: 1,779.00
Change: 7.00 (0.39%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,786.50
Low: 1,771.50
Prev. Close: 1,773.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Healthcare, financials stocks drag FTSE 100 lower; DS Smith outperforms

Tue, 07th Sep 2021 09:28

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Broker TP ICAP slips as first-half profit falls

* UK PM raises taxes to tackle health crisis

* 888 in talks to buy William Hill's non-U.S. assets; shares
down

* FTSE 100 down 0.5%, FTSE 250 off 0.6%
(Updates to close)

By Devik Jain and Amal S

Sept 7 (Reuters) - London's FTSE 100 index ended lower on
Tuesday, weighed down by healthcare stocks and brokerages, while
DS Smith jumped to the top of the index after an upbeat trading
update.

The blue-chip index fell 0.5% and marked its worst
session in nearly three weeks, as healthcare
weighed with drugmakers AstraZeneca and GlaxoSmithKline
among top drags.

Investment banking and brokerage services providers
shed 1% after TP ICAP Group Plc reported a lower
half-year profit.. Shares of the world's largest
inter-dealer broker slipped 10.7%.

DS Smith jumped 2.8% to the top of the index as
J.P. Morgan raised its price target on the cardboard maker's
stock after it said trading continued to progress well in line
with the trends.

European stocks edged down as investors awaited the European
Central Bank's policy meeting on Thursday for clues on how the
crisis-fighting measures would be dismantled.

"After a weak US jobs report last Friday prompted
speculation the Federal Reserve would hold off on tapering
support for the economy, attention will switch to the European
Central Bank this week as it unveils its latest decision on
monetary policy on Thursday," said Russ Mould, investment
director at AJ Bell.

Meanwhile, British Prime Minister Boris Johnson set out
plans to raise taxes on workers, employers and some investors to
try to fix a health and social care funding crisis sending pound
down.

The domestically focused mid-cap FTSE 250 index was
down 0.6% dragged by industrial stocks.

Among individual stocks, 888 fell 1.8% after the
British gambling group said it was in advanced talks with
Caesars Entertainment for a possible acquisition of the
international operations of the U.S. company's William Hill
business.

Meggitt Plc fell 12.1% to the bottom of mid-cap
index after aerospace parts maker TransDigm bowed out of
an $8.7 billion takeover battle with fellow U.S. bidder
Parker-Hannifin for the British engineering firm.
(Reporting by Devik Jain and Amal S in Bengaluru; Editing by
Saumyadeb Chakrabarty and Uttaresh.V, Editing by William
Maclean)

More News
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.